Professional Profile and Leadership Experience
Mika Newton serves as the Chief Executive Officer (CEO) of xCures, a healthcare technology company pioneering AI-powered medical data solutions specialized in personalized treatment and clinical decision support. He possesses over 25 years of leadership experience in life sciences and healthcare, with notable expertise in healthcare data management emphasizing data completeness and universality. His commercial strategy acumen focuses on novel technologies with a consistent track record of enabling transformative healthcare innovations and scaling data analytics companies.
Prior to his current role at xCures, Mika held several senior executive positions including:
- Chief Commercial Officer, Doctor Evidence, LLC
- General Manager of Clinical Development Services, diaDexus
- Senior Vice President of Client and Market Development, Evidera
- Vice President of Sales and Marketing, Archimedes
- Sales management and operations roles at Quintiles, Invitrogen, and Tripos
His extensive background spans commercial leadership, sales strategy, clinical development services, and market growth within biotech and pharmaceutical sectors.
Company Overview and Strategic Role
xCures is a trailblazer in AI-assisted healthcare technology, launched in 2018, that automatically retrieves and aggregates comprehensive medical records from any U.S. care site within 15 minutes, transforming raw data into sophisticated, longitudinal patient health profiles that include clinical, genomic, imaging, and social determinants of health.
- Under Mika’s leadership, xCures has:
- Secured significant funding and developed an expanding product portfolio.
- Forged strategic partnerships with industry stakeholders, enhancing the company’s position in the personalized medicine ecosystem.
- Achieved recognition through patents including USPTO Patent No. 11,887,738 related to AI technology for virtual clinical trials and continuous learning from patient data.
- The company’s platform:
- Initially designed for oncology, it expanded in early 2024 to support real-time, regulatory-grade data across all therapeutic areas, enhancing its applicability to any U.S. patient's medical record.
- Employs AI/ML to extract, aggregate, and structure data into a searchable digital record facilitating informed, patient-centric clinical and research insights.
- Offers access through software licensing and APIs, embedding into healthcare workflow management platforms.
- Provides de-identified real-world datasets to support secondary research and accelerate biomedical research and drug development.
Recognition and Industry Influence
- Accepted into the Forbes Technology Council (January 2025), attributed to a diverse and deep leadership background and a demonstrated impact in healthcare technology innovation.
- Frequently invited as a speaker and panel chair at high-profile industry events such as PMWC 2024, where he chaired sessions on Real-World Evidence (RWE) and Real-World Data (RWD), emphasizing the integration of patient-centric data in drug development and clinical decision support.
- Engaged in thought leadership addressing challenges in healthcare data management and AI-enhanced telehealth delivery, including presentations at HLTH US 2024 and ATA Nexus Conference (2025).
- Leads discussions on leveraging AI for improved clinical decision-making and expanding access to guideline-recommended care.
Notable Achievements and Contributions
- Spearheaded the successful expansion of xCures’ AI platform beyond oncology in 2024, marking a significant milestone enabling comprehensive healthcare data transformation across multiple disease areas.
- Contributed to the unveiling of next-generation AI-powered data platforms that facilitate clinical clarity from complex medical records, supporting healthcare providers and researchers.
- Oversees the continuous innovation of xCures' technology that converts heterogeneous medical data into actionable insights, accelerating precision medicine and patient care outcomes.
- Advocates for data privacy and regulatory oversight in the evolving AI-healthcare interface, emphasizing the need for safeguarding patient information in an AI-driven ecosystem.
Organizational Context
Mika Newton leads a multidisciplinary team at xCures, headquartered in Oakland, CA, with clinical and data operations in Raleigh, NC. The management team includes experts in AI, data science, clinical operations, and product development, supporting the company’s mission to disrupt oncology and broader healthcare markets with AI-powered solutions. The company is supported by a prominent Board of Directors and Medical & Scientific Advisors, reflecting strong scientific, clinical, and entrepreneurial expertise.
This comprehensive profile reflects Mika Newton’s strategic role in advancing AI-driven healthcare data technologies and his strong influence in the life sciences domain, positioning xCures as a leading innovator in precision medicine and real-world evidence application.
